茂盛控股(00022.HK)中期虧損擴大8.02%至2403.8萬港元
格隆匯 11 月 25日丨茂盛控股(00022.HK)公佈,截至2020年9月30日止6個月,公司實現收入894.7萬港元,同比減少72.55%;公司擁有人應占期內虧損2403.8萬港元,同比擴大8.02%;基本每股虧損1.222港仙。
期內虧損主要歸因於COVID-19疫情導致跨境旅遊近乎停頓,給經濟帶來嚴峻衝擊,致令收益大幅下跌。根據香港旅遊發展局公佈的數據顯示,回顧期內每月旅客人數下跌超過99%,而於期內香港各類受訪酒店之平均酒店客房入住率為44%,而去年同期的相應平均入住率為80%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.